Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000731061 | SCV000858832 | uncertain significance | not provided | 2018-01-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003758918 | SCV004404209 | uncertain significance | Episodic kinesigenic dyskinesia | 2022-12-09 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PRRT2 protein function. This sequence change replaces lysine, which is basic and polar, with isoleucine, which is neutral and non-polar, at codon 116 of the PRRT2 protein (p.Lys116Ile). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PRRT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 595501). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000731061 | SCV005385605 | uncertain significance | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |